Exicure Stock Investor Sentiment

XCUR Stock  USD 10.03  0.06  0.59%   
Slightly above 59% of all Exicure's retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Exicure suggests that some traders are interested. Exicure's investing sentiment overview a quick insight into current market opportunities from investing in Exicure. Many technical investors use Exicure stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

Exicure Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Exicure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at www.macroaxis.com         
Acquisition by Muralidhar Bali of 50000 shares of Exicure subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Exicure Stock Soars Over 25 percent On Acquisition Of GPCR Therapeutics U.S. Unit Retail Chatter Spi...
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Short Interest in Exicure, Inc. Drops By 17.3
news
over two weeks ago at news.google.com         
Exicure Stock Soars Over 25 percent On Acquisition Of GPCR Therapeutics U.S. Unit Retail Chatter Spi...
Google News at Macroaxis
over three weeks ago at businesswire.com         
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
businesswire News
over three weeks ago at seekingalpha.com         
Exicure signs purchase agreement with GPCR Therapeutics
seekingalpha News
over three weeks ago at news.google.com         
Exicure Acquires GPCR Therapeutics USA in Major Strategic Expansion, Signs Milestone Licensing Deal ...
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Kim Helen Susan of 21693 shares of Exicure at 2.79 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Exicure Secures 8.7 Million in Stock Purchase Deal - MSN
Google News at Macroaxis
over a month ago at news.google.com         
Exicure Secures 8.7 Million in Stock Purchase Deal - TipRanks
Google News at Macroaxis
over a month ago at seekingalpha.com         
Exicure joins hands with GPCR Therapeutics for growth in biotech
seekingalpha News
over a month ago at businesswire.com         
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the 8.7 Million Equity Financi...
businesswire News
over a month ago at businesswire.com         
Exicure, Inc. Announces Shareholders Approve the 8.7 Million Equity Financing and Reports Executive ...
businesswire News
over two months ago at news.google.com         
Exicure boosts equity, eyes Nasdaq compliance - Investing.com
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Exicure that are available to investors today. That information is available publicly through Exicure media outlets and privately through word of mouth or via Exicure internal channels. However, regardless of the origin, that massive amount of Exicure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Exicure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Exicure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Exicure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Exicure alpha.

Exicure Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Is Exicure gaining more confidence from retail investors
11/22/2024
2
Exicure Stock Soars to 52-Week High, Hits 32.75 - Investing.com
11/27/2024
3
Disposition of 3400000 shares by Cbi Usa, Inc. of Exicure at 1.6 subject to Rule 16b-3
12/03/2024
4
Disposition of 3400000 shares by Dgp Co., Ltd. of Exicure at 1.32 subject to Rule 16b-3
12/10/2024
5
Insider Trading
12/12/2024
6
Exicure, Inc. Announces Shareholders Approve the 8.7 Million Equity Financing and Reports Executive Management and Board Changes
12/20/2024
7
Exicure Secures 8.7 Million in Stock Purchase Deal - TipRanks
01/06/2025
8
Acquisition by Kim Helen Susan of 21693 shares of Exicure at 2.79 subject to Rule 16b-3
01/17/2025
9
Exicure signs purchase agreement with GPCR Therapeutics
01/22/2025
10
Acquisition by Muralidhar Bali of 50000 shares of Exicure subject to Rule 16b-3
02/11/2025

Additional Tools for Exicure Stock Analysis

When running Exicure's price analysis, check to measure Exicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exicure is operating at the current time. Most of Exicure's value examination focuses on studying past and present price action to predict the probability of Exicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exicure's price. Additionally, you may evaluate how the addition of Exicure to your portfolios can decrease your overall portfolio volatility.